The Online Books Page

Geriatric pharmacology -- United States

See also what's at your library, or elsewhere.

• Geriatric pharmacology
• Pharmacology -- United States
• United States

• Geriatric pharmacology -- United States -- Directories

• Prescription drugs and the elderly the high cost of growing old : hearing before the Special Committee on Aging, United States Senate, One hundredth Congress, first session, Washington, DC, July 20, 1987. (U.S. G.P.O., 1987), by United States Senate Special Committee on Aging (page images at HathiTrust)
• Prescription drug costs the growing burden for older Americans : hearing before the Special Committee on Aging, United States Senate, One Hundredth Congress, first session, Little Rock, AR, August 27, 1987. (U.S. G.P.O., 1988), by United States Senate Special Committee on Aging (page images at HathiTrust)
• Medicare's new prescription drug coverage a major step forward, but big problems still exist : staff report to the Special Committee on Aging, United States Senate. (U.S. G.P.O., 1988), by United States Senate Special Committee on Aging (page images at HathiTrust)
• Medicare's new prescription drug coverage : a major step forward, but big problems still exist : staff report to the Special Committee on Aging, United States Senate. (U.S. G.P.O. :, 1988), by United States Senate Special Committee on Aging (page images at HathiTrust)
• Prescription drug costs : the growing burden for older Americans : hearing before the Special Committee on Aging, United States Senate, One Hundredth Congress, first session, Little Rock, AR, August 27, 1987. (U.S. G.P.O. :, 1988), by United States Senate Special Committee on Aging (page images at HathiTrust)
• Pharmacy and the elderly : an assessment of pharmacy education based on the needs of the elderly and recommendations for increasing geriatric aspects of pharmacy curricula (Dept. of Health, Education, and Welfare, Public Health Service, Health Resources Administration, Bureau of Health Manpower, 1979), by D.C.) Center for Human Services (Washington and United States. Health Resources Administration. Bureau of Health Manpower (page images at HathiTrust)

• Prescription drug programs for older Americans (annotated) : (includes a directory of pharmaceutical manufacturer indigent patient programs) : a staff report of the Special Committee on Aging, United States Senate. (U.S. G.P.O. :, 1993), by United States Senate Special Committee on Aging (page images at HathiTrust)

Items below (if any) are from related and broader terms.

• Prescription drugs and elderly Americans : ambulatory use and approaches to coverage for Medicare : staff paper (United States Congress, Office of Technology Assessment, Health Program, 1987), by United States. Congress. Office of Technology Assessment. Health Program (page images at HathiTrust)
• You and your medicines : guidelines for older Americans : an information paper (U.S. G.P.O., 1983), by United States Senate Special Committee on Aging (page images at HathiTrust)
• A resource guide for drug management programs for older persons (U.S. Dept. of Health and Human Services, Office of Human Development Services, Administration on Aging, 1987), by Marjorie Bogaert-Tullis, San Francisco. Aging Health Policy Center University of California, San Francisco. National Policy Center on Health University of California, and United States. Administration on Aging (page images at HathiTrust)

• Medication and the elderly : January 1985 through December 1989 (U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Library of Medicine, Reference Section ;, 1989), by Jacqueline Van de Kamp (page images at HathiTrust)

• A Consumer guide to prescription drug use for older Americans : a report by the chairman of the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, One Hundred Second Congress, first session. (U.S. G.P.O. :, 1991), by United States. Congress. House. Select Committee on Aging. Subcommittee on Housing and Consumer Interests (page images at HathiTrust)

• Pharmacology at the Uniformed Services University of the Health Sciences. (Dept. of Defense, 1990), by United States. Dept. of Defense (page images at HathiTrust)
• Medicines for drug abuse : reviewing the strategy : hearing before the Committee on the Judiciary, United States Senate, One Hundred Third Congress, second session ... April 19, 1994. (U.S. G.P.O. :, 1995), by United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Juvenile Justice (page images at HathiTrust)
• Drugs of abuse : chemistry, pharmacology, immunology, and AIDS (U.S. Dept. of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Drug Abuse ;, 1990), by Phuong Thi Kim Pham, Kenner Rice, and National Institute on Drug Abuse (page images at HathiTrust)

• Sources in the history of American pharmacology (American Institute of the History of Pharmacy, 1983), by John Parascandola and Elizabeth Keeney (page images at HathiTrust)

• Sources in the history of American pharmacology (American Institute of the History of Pharmacy, 1983), by John Parascandola and Elizabeth Keeney (page images at HathiTrust)

• Sources in the history of American pharmacology (American Institute of the History of Pharmacy, 1983), by John Parascandola and Elizabeth Keeney (page images at HathiTrust)

• Annual report for fiscal year ... (U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1980), by Pharmacological Sciences Program (National Institute of General Medical Sciences) (page images at HathiTrust)

• Drug discovery, databases, and computer-aided drug design. (U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Institute on Drug Abuse, 1993), by Richard L. Hawks, Rao S. Rapaka, and National Institute on Drug Abuse (page images at HathiTrust)

• Food and Drug Administration's Critical Path Initiative : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Tenth Congress, first session, special hearing, June 1, 2007, Salt Lake City, Utah. (U.S. G.P.O. :, 2008), by Rural Development United States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture (page images at HathiTrust)
• Norplant and contraceptive pricing : conflict of interest, protection of public ownership in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session. (U.S. G.P.O. :, 1994), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)
• Oversight of the drug development program of the National Cancer Institute, 1982 : hearing before the Subcommittee on Investigations and General Oversight of the Committee on Labor and Human Resources, United States Senate, Ninety-seventh Congress, second session on examination of effective alternatives toward correcting deficiencies in the use of experimental drugs on cancer patients, March 5, 1982. (U.S. G.P.O. :, 1982), by United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Investigations and General Oversight (page images at HathiTrust)

• Follow-on biologics : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007. (U.S. G.P.O. :, 2008), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
• Biologics and biosimilars : balancing incentives for innovation : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, July 14, 2009. (U.S. G.P.O. :, 2010), by United States. Congress. House. Committee on the Judiciary. Subcommittee on Courts and Competition Policy (page images at HathiTrust)
• Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session. (U.S. G.P.O. :, 1993), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)
• PDUFA 5 (U.S. G.P.O. :, 2012), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (page images at HathiTrust)
• Food and Drug Administration's review process for products to treat rare diseases and neglected tropical diseases : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Eleventh Congress, second session, special hearing, June 23, 2010, Washington, D.C (U.S. G.P.O. :, 2011), by Rural Development United States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture (page images at HathiTrust)

• Development of electrophysiological indices of neurological toxicity for organophosphate pesticides and depressant drugs (U. S. Dept. of Transportation, Federal Aviation Administration, Office of Aviation Medicine, 1979), by Alvin M Revzin, Civil Aeromedical Institute, and United States. Office of Aviation Medicine (page images at HathiTrust)

• Pediatric Research Equity Act of 2003 : report together with additional views (to accompany S. 650). (U.S. G.P.O., 2003), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
• Discussion drafts concerning Prescription Drug User Fee Act reauthorization, Medical Device User Fee and Modernization Act reauthorization, drug safety, and certain pediatric pharmaceutical and device legislation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, June 12, 2007. (U.S. G.P.O. :, 2008), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (page images at HathiTrust)
• Amending the Federal Food, Drug, and Cosmetic Act to require labeling containing information applicable to pediatric patients : report together with additional views (to accompany S. 2394). (U.S. G.P.O., 2002), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
• Programs affecting safety and innovation in pediatric therapies : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 22, 2007. (U.S. G.P.O. :, 2008), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (page images at HathiTrust)
• Better pharmaceuticals for children : assessment and opportunities : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, first session ... May 8, 2001. (U.S. G.P.O. :, 2001), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
• Ensuring safe medicines and medical devices for children : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining ensuring safe medicines and medical devices for children, March 27, 2007. (U.S. G.P.O. :, 2008), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
• Best Pharmaceuticals for Children Act : report (to accompany S. 838). (U.S. G.P.O., 2001), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
• Best Pharmaceuticals for Children Act : report together with dissenting views (to accompany H.R. 2887) (including cost estimate of the Congressional Budget Office). (U.S. G.P.O., 2001), by United States House. Committee on Energy and Commerce (page images at HathiTrust)
• Evaluating the effectiveness of the Food And Drug Administration Modernization Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, May 3, 2001. (U.S. G.P.O. :, 2001), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (page images at HathiTrust)

• Pharmacy museums (American Institute of the History of Pharmacy, 1956), by George B. Griffenhagen (page images at HathiTrust)

• Pharmacy museums and historical collections on public view in the United States and Canada (American Institute of the History of Pharmacy, 1981), by Sami Khalaf Hamarneh and Ernst Walter Stieb (page images at HathiTrust)
• Pharmacy museums and historical collections in the United States and Canada (American Institute of the History of Pharmacy, 1988), by George B. Griffenhagen and Ernst Walter Stieb (page images at HathiTrust)
• Pharmacy museums and historical collections on public view, U.S.A. (American Institute of the History of Pharmacy, 1972), by Sami Khalaf Hamarneh (page images at HathiTrust)
• Pharmacy museums and historical collections. (American Institute of the History of Pharmacy, 1999), by George B. Griffenhagen, Beth D. Fisher, Ernst Walter Stieb, and American Institute of the History of Pharmacy (page images at HathiTrust)

• Adequacy of access to investigative drugs for seriously ill patients : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, September 23, 1997. (U.S. G.P.O. :, 1997), by United States House Committee on Commerce, Subcommittee on Oversight and Investigations (page images at HathiTrust)
• Compassionate use of investigational new drugs : is the current process effective? : hearing before the Committee on Government Reform, House of Representatives, One Hundred Seventh Congress, first session, June 20, 2001. (U.S. G.P.O. :, 2002), by United State House Committee on Government Reform (page images at HathiTrust)

• Expanding Access to Investigational Therapies for HIV Infection and AIDS: March 12-13, 1990, Conference Summary (1991), by Eve K. Nichols (page images with commentary at NAP)

• FDA and the veterinarian. (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Veterinary Medicine, 1994), by Center for Veterinary Medicine (U.S.) (page images at HathiTrust)

• Preamble compilation : Animal drugs, feeds, & related products March 1936-March 1978. (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration ;, 1981), by United States Food and Drug Administration (page images at HathiTrust)
• FDA and the veterinarian. (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Veterinary Medicine, 1994), by Center for Veterinary Medicine (U.S.) (page images at HathiTrust)

• Medicines : the inside story (American Institute of the History of Pharmacy, 1996), by Michael R. Harris, Mark Parascandola, Task Force for Child Survival and Development, Glaxo Wellcome, and American Institute of the History of Pharmacy (page images at HathiTrust)

More items available under broader and related terms at left.